Department Introduction

Rheumatology and Immunology | Our Speciality

:::

Our Speciality

Management of Refractory Autoinflammatory Diseases (Primarily Adult-Onset Still’s Disease/AOSD)

▪ Provides a comprehensive one-stop medical service for AOSD.
▪ SNQ National Quality Certification (2022-2024).
▪ 35 SCI-indexed publications—the highest number of single-center publications globally.
▪ Research findings have been widely cited over 1,500 times and have received four patents (two from the United States and two from Taiwan).

Innovative allogeneic adipose-derived stem cell therapy for Connective Tissue Diseases with Interstitial Lung Disease (ILD)

▪ Conducting a Phase I/IIa clinical trial, which has been approved by Taiwan’s Ministry of Health and Welfare.

Personalized Screening and Prevention for Rheumatic Disease Comorbidities

▪ A patient-centered case management system with Risk Management Plans (RMPs), ensuring zero adverse events in the past 10 years.
▪ 20 SCI-indexed publications.
▪ Two patents (one in the United States and one in Taiwan).
▪ Developing the first Asia-Pacific guidelines for RA comorbidity prevention and management, cited 37 times in the past three years.

Stay connected with CMUH
How to get to CMUH the map of hospital
百度 搜狗 360搜索 “你来我家干嘛”#县城文学 铁血战士:猎物 大V:尹锡悦被罢免并非其终点 清明节其实融合了三个节 美防部调查防长涉“群聊泄密”事件

      <code id='e9247'></code><style id='c3db7'></style>
    • <acronym id='a49de'></acronym>
      <center id='c14ba'><center id='4d524'><tfoot id='2101f'></tfoot></center><abbr id='e13c3'><dir id='74406'><tfoot id='56224'></tfoot><noframes id='51925'>

    • <optgroup id='9cc4a'><strike id='61712'><sup id='e3531'></sup></strike><code id='7d326'></code></optgroup>
        1. <b id='50bbe'><label id='e5b60'><select id='0f6f7'><dt id='2529e'><span id='9e346'></span></dt></select></label></b><u id='b5afb'></u>
          <i id='c771a'><strike id='3ba30'><tt id='cd59d'><pre id='3186b'></pre></tt></strike></i>